We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Invitrogen Licenses Technology for Fluorescent microRNA Labeling Kits

By Biotechdaily staff writers
Posted on 11 Mar 2008
Using Genisphere Inc.'s (Hatfield, PA, USA) 3DNA dendrimer signal amplification technology, Invitrogen Corp. More...
(Carlsbad, CA, USA) will become the exclusive provider of fluorescent microRNA (miRNA) microarray labeling kits, according to a new license agreement. Genisphere's technology is combined with Invitrogen's Alexa Fluor fluorescent dyes and commercialized in the new NCode rapid miRNA labeling system, which is available from Invitrogen.

Genisphere's 3DNA dendrimer technology is based on highly branched DNA structures serving as scaffolds for multitudes of fluorescent dyes. As a class, dendrimers are complex, branched molecules built from interconnected natural or synthetic monomeric subunits. A 3DNA dendrimer is constructed from DNA monomers, as the name "3DNA” indicates.

Each 3DNA monomer is composed of two DNA strands that share a region of sequence complementarily located in the central portion of each strand. When the two strands anneal to form the monomer the resulting structure has a central double-stranded "waist” bordered by four single-stranded "arms.” This waist plus arms structure comprises the basic 3DNA monomer.

"Our new kit accelerates the discovery of novel miRNA biomarkers by reducing the amount of time scientists must invest to detect miRNAs. In addition, we have increased sensitivity compared to alternative technologies, which can preserve precious samples,” said Peter Welch, director of research and development, gene expression profiling at Invitrogen. "Because miRNAs play a significant role in cancer and in the differentiation of stem cells, discoveries resulting from experiments in those areas could potentially expedite the diagnostics applications of miRNA biomarkers in disease.”


Related Links:
Genisphere
Invitrogen

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Chromogenic Culture System
InTray™ COLOREX™ ECC
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.